The anabolic agent Trienbolone acetate (3-oxo-17-β-hydroxy-4,9,11-estratriene acetate) given subcutaneously to female rats increased their growth rate compared with untreated controls (P < 0.001). 2. The compound had little androgenic activity. 3. The fractional synthetic and fractional degradative rates of the mixed muscle proteins were smaller in the treated rats than in the control rats.
No takes yet. Share an insight, caveat, or question.
Vernon et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: